Table 3.
Cytotoxicity and antiviral effects against ZIKV upon treatment of Vero cells with naringenin, 7-O-methyl naringenin and 6-MMPr.
d# CC20 (μM/mL) | a# CC50 (μM/mL) | b# IC50 (μM/mL) | c# SI | |
---|---|---|---|---|
Naringenin | 86.43 | 241.6 | 58.89 | 4.1 |
7-O-methyl naringenin | 105.2 | 240.4 | 12.80 | 18.7 |
6-MMPr | 60.5 | 291 | 24.5 | 11.9 |
a CC50 (50% cytotoxic concentration) compound concentration to reduce 50% of viability. b IC50 (50% inhibitory concentration) compound concentration to reduce 50% viral titer when compared with untreated cells. c Selective index (SI) based on the ratio calculation of CC50 and IC50 values. d CC20 (20% cytotoxic concentration), the non-toxic concentration used in the antiviral assays. # Results are defined by the mean values of three independent experiments.